Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
30 EVENTS
Established ICO Corporation (now WDB Coco Corporation) in Chuo-ku, Tokyo, with capital of 4 million yen
Started translation services for pharmaceuticals, medical, and life sciences
Increased capital to 8 million yen
Increased capital to 32 million yen
Started document preparation services related to pharmaceutical affairs applications
Relocated headquarters to Tamon-do Building, 2-13-19 Akasaka, Minato-ku, Tokyo
Became a wholly owned subsidiary of WDB Corporation (now WDB Holdings Corporation)
Relocated headquarters to Mitsubishi Research Institute Building, 2-3-6 Otemachi, Chiyoda-ku, Tokyo
Relocated headquarters to Nippon Building, 2-6-2 Otemachi, Chiyoda-ku, Tokyo
Merged with WDB Medical Corporation
Expanded business by inheriting safety information and pharmaceutical application services (creation, QC, operations) and regular dispatch services
Changed company name to WDB ICO Corporation
Established Tokyo Data Center (now Tokyo Operation Center)
Increased capital to 50 million yen
Start clinical research support services
Relocate headquarters to 1-2-16 Yaesu, Chuo-ku, Tokyo, TG Building Main Building
Establish Kansai Office and Kobe Data Center (currently Kobe Operation Center)
Change trade name to WDB Kokko Corporation
Relocate headquarters and Tokyo Data Center (currently Tokyo Operation Center) to 1-8-11 Harumi, Chuo-ku, Tokyo, Triton Square Y
Listed on Tokyo Stock Exchange Mothers
Increase capital to 250,580,000 yen
Increase capital to 269,690,000 yen
Increase capital to 275,940,000 yen
Transition to Tokyo Stock Exchange Growth Market
Increase capital to 279,240,000 yen
Make WDB Clinical Research Corporation a wholly owned subsidiary through share acquisition
Absorb and merge WDB Clinical Research Corporation
Increase capital to 279,980,000 yen
Establish Kobe Training Center
Establish Osaka Operation Center
§07
News
1 ARTICLES
Seminar: Updated Practices in Pharmacovigilance Across Asia
WDB Coco Co., Ltd. will host a free seminar led by Hiroyuki Yoshimura, who has overseen pharmacovigilance (PV) activities in 11 Asian countries. The seminar will explain tightening PV regulations in Asia aligned with European and US standards, as well as practical points for building operational frameworks. It will also answer questions submitted in advance and introduce the company's Asian PV expansion support services and contract case studies.
§08
Public records
GOV
National Tax Agency basic information9010001139654
Source: National Tax Agency Corporate Number Publication Site, basic three items